Cargando…
Novel haemodialysis (HD) treatment employing molecular hydrogen (H(2))-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational study
Recent studies have revealed unique biological characteristics of molecular hydrogen (H(2)) as an anti-inflammatory agent. We developed a novel haemodialysis (E-HD) system delivering an H(2) (30–80 ppb)-enriched dialysis solution by water electrolysis, and conducted a non-randomized, non-blinded, pr...
Autores principales: | Nakayama, Masaaki, Itami, Noritomo, Suzuki, Hodaka, Hamada, Hiromi, Yamamoto, Ryo, Tsunoda, Kazumasa, Osaka, Naoyuki, Nakano, Hirofumi, Maruyama, Yukio, Kabayama, Shigeru, Nakazawa, Ryoichi, Miyazaki, Mariko, Ito, Sadayoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762770/ https://www.ncbi.nlm.nih.gov/pubmed/29321509 http://dx.doi.org/10.1038/s41598-017-18537-x |
Ejemplares similares
-
Possible clinical effects of molecular hydrogen (H(2)) delivery during hemodialysis in chronic dialysis patients: Interim analysis in a 12 month observation
por: Nakayama, Masaaki, et al.
Publicado: (2017) -
Comparisons of fatigue between dialysis modalities: A cross-sectional study
por: Maruyama, Yukio, et al.
Publicado: (2021) -
Peritoneal Dialysis or Haemodialysis for Kidney Failure?
por: Man Shrestha, Badri
Publicado: (2018) -
Dissolved molecular hydrogen (H(2)) in Peritoneal Dialysis (PD) solutions preserves mesothelial cells and peritoneal membrane integrity
por: Nakayama, Masaaki, et al.
Publicado: (2017) -
Multipass haemodialysis: a novel dialysis modality
por: Heaf, James Goya, et al.
Publicado: (2013)